EQRx, Inc.
From EverybodyWiki Bios & Wiki
| ISIN | 🆔 |
|---|---|
| Founded 📆 | 2019 |
| Founder 👔 | |
| Headquarters 🏙️ | , Cambridge, Massachusetts, United States |
Area served 🗺️ | |
| Members | |
Number of employees | |
| 🌐 Website | https://www.eqrx.com |
| 📇 Address | |
| 📞 telephone | |
EQRx is a biotechnology company that focuses on reengineering the process of drug discovery to make drugs affordable.[citation needed] They also aim to make drug pricing transparent.[1]
EQRx was founded in 2019 by Alexis Borisy, Peter Bach and Sandra Horning, and is based in Cambridge, Massachusetts, United States.[citation needed] Their stock symbol is NASDAQ:EQRX and IPO date is December 17, 2021.
References
- ↑ "Get to know EQRx". EQRx. Retrieved 2022-03-25.
This article "EQRx" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:EQRx. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
